Infinium Global Research Conjunctivitis Market | Page 2

A latest report has been added to the wide database of Conjunctivitis Market by Infinium Global Research.
This report studies the Conjunctivitis Market by disease type (bacterial conjunctivitis, viral conjunctivitis,
allergic conjunctivitis) market status and outlook of global and major regions, from manufacturers, and end
industries. The objective of the study is to identify market sizes of different segments & countries in recent
years and to forecast the values for the next six years. Conjunctivitis Market provides opportunities in micro
markets for stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and
product offerings of the major companies in the Conjunctivitis Market. According to the report the Global
Conjunctivitis Market is projected to grow at a CAGR of 2.1% in terms of value over the period of 2017-2023.
Conjunctivitis or pink eye is an inflammation or redness of the lining of the white part of the eye and the
underside of the eyelid that can be caused by infection, allergic reaction, or physical agents like infrared or
ultraviolet light. Conjunctivitis is an extremely common eye problem because the conjunctiva is continually
exposed to microorganisms and environmental agents that can cause infections or allergic reactions. It can
also affect one or both eyes and, if caused by infection, can be very easily transmitted to others during close
physical contact, particularly among children in a daycare center. Thus, people diagnosed with conjunctivitis
are recommended not to travel public places for that period of time.
Market Insights
Increasing awareness among patient population about pink eye disease, entry of new drugs and unmet need
for viral conjunctivitis are considered to be the key factors driving the growth of this market. Unfavorable
government regulations, expiring drug patents of major blockbusters and the growing demand for
antibacterial drugs has impacted the demand for branded drugs are the key restraining factors for the growth
of this market. Since, there are no approved drugs for the treatment of viral conjunctivitis, many companies
are developing drugs which are expected to aid in the treatment of viral conjunctivitis and their effect will turn
into a prominent opportunity to promote growth of this market over the forecast period. Moreover, loss of
patent exclusivities and increasing demand for generic antibacterial drugs over branded drugs are the major
challenges faced by this market.